FlexGen, BGI and LUMC collaborate in Target Enrichment experiment

Published : Wednesday, January 25, 2012
FlexGen, BGI and LUMC collaborate in Target Enrichment experiment

In a collaborative effort FlexGen BV, Leiden University Medical Center (LUMC) and BGI will validate a set of variants in a large set of trio samples from the Genome of the Netherlands (GoNL) project. The experiment will take place at the BGI facilities in China in Q1 2012.





FlexGen – based in the Leiden Bio Science Park in the Netherlands - was founded in December 2004 as a spin off from Leiden University Medical Centre and Dutch Space (part of EADS). Anticipating a rapidly growing genetic research market, FlexGen developed a proprietary technology for synthesizing custom oligonucleotides. The platform is now used for a variety of applications including production of in-solution target enrichment kits, FleXelect.